Your browser doesn't support javascript.
loading
CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines.
Lee, DA Sol; Han, Min Woo; Kang, Yonghyun; Kim, Chorong; Lee, Seonmin; Kim, Kyu-Pyo; Yoo, Changhoon.
Afiliación
  • Lee DS; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
  • Han MW; University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kang Y; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
  • Kim C; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
  • Lee S; University of Ulsan Digestive Diseases Research Center, Seoul, Republic of Korea.
  • Kim KP; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea yooc@amc.seoul.kr.
Anticancer Res ; 44(5): 1939-1946, 2024 May.
Article en En | MEDLINE | ID: mdl-38677763

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fenazinas / Pinocitosis / Piperazinas / Neoplasias de los Conductos Biliares / Proteínas Proto-Oncogénicas p21(ras) / Colangiocarcinoma / Quinasa de la Caseína II / Lisosomas / Mutación / Naftiridinas Límite: Humans Idioma: En Revista: Anticancer Res Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fenazinas / Pinocitosis / Piperazinas / Neoplasias de los Conductos Biliares / Proteínas Proto-Oncogénicas p21(ras) / Colangiocarcinoma / Quinasa de la Caseína II / Lisosomas / Mutación / Naftiridinas Límite: Humans Idioma: En Revista: Anticancer Res Año: 2024 Tipo del documento: Article